Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetics of Antidepressants in Mexican-Americans
NCT00265291Phase 2Completed
- Sponsor
- National Institute of General Medical Sciences
- Start
- Nov 1999
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine, desipramine in major depressive disorder (MDD), sponsored by National Institute of General Medical Sciences. Started Nov 1999; status: completed.
02
Drugs
fluoxetinedesipramine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00265291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265291.